EATG » Scientific research

Scientific research

Researchers create molecule that could ‘kick and kill’ HIV

In lab animals, a particle developed by UCLA, Stanford, NIH scientists awakens dormant virus cells and then knocks them out Current anti-AIDS drugs are highly effective at making HIV undetectable…

Scientists bring new insights into the heritability of HIV infection severity

HIV's pernicious persistence in human populations -- despite more than 25 years of heroic HIV research efforts --owes in part to its particular abilities to exploit its human hosts, constantly…

When HIV drugs don’t cooperate

The term “synergy” has gained a reputation as an overused buzzword, but it has a quantifiable definition in pharmacology. Two drugs are considered synergistic when their effectiveness when used together…

Promising HIV treatments in late-stage clinical development

Despite the abundance of HIV medications, analysts have identified several unmet needs in the marketplace. Read the full analysis published in P&T Community here.

HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials

September 27, 2017 – The effectiveness of pre-exposure prophylaxis (PrEP) with the antiretroviral drug combination TDF/FTC (Truvada) raises questions regarding the design and conduct of trials of other candidate biomedical HIV…

Scientists develop a 10-second HIV test linked to mobile phones

Researchers from a group of UK universities have developed a 10-second test for HIV, based on mobile phone technology. The University of Surrey, working with colleagues at University College London,…

Replicor announces publication of its REP 301 study in HBV/HDV co-infection

MONTREAL, September 28, 2017 – Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic HBV and hepatitis delta virus…

The Campbell Foundation awards grant to develop gene editing tool to destroy latent HIV cells in lymph nodes

Sept. 26, 2017 – FORT LAUDERDALE, FL –  The Campbell Foundation, a nonprofit organization dedicated to funding HIV/AIDS research, has awarded an $80,000 grant to Kristine Yoder, PhD, to develop…

Synthetic molecule ‘kicks and kills’ some persistent HIV in mice

New compound shows early promise as potential treatment for dormant HIV infection Scientists have designed a synthetic molecule that can reactivate dormant human immunodeficiency virus (HIV) in mice and lead…

Three-in-one antibody protects monkeys from HIV-like virus

NIH and Sanofi scientists prepare to test antibody in people. A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of…

1 3 4 5 6 7 28